1 year return (CAGR)
266.83%
Nuvectis Pharma Inc Exchange (NASDAQ, USD)
NVCT
23.00
+1.02 (+4.64%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
16.41%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
750.81M
Price/Sales
-
Ent value
741.95M
Price/Book
82.67
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 22.26 |
| Daily high | 23.16 |
| Daily low | 21.79 |
| Daily Volume | 124K |
| All-time high | 28.53 |
| 1y analyst estimate | 35.40 |
| Beta | -0.26 |
| EPS (TTM) | -1.19 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 10 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NVCT | S&P500 | |
| Current price drop from All-time high | -19.38% | -0.58% |
| Highest price drop | -77.59% | -56.47% |
| Date of highest drop | 23 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -51.50% | -10.68% |
| Avg time to new high | 73 days | 12 days |
| Max time to new high | 1028 days | 1805 days |
News
